Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts).
about
Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injuryThe influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosisPulmonary fibrosis: pathogenesis, etiology and regulationPulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases.Bronchoalveolar lavage in lung transplantation. State of the art.Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up.Arterial Carboxyhemoglobin Measurement Is Useful for Evaluating Pulmonary Inflammation in Subjects with Interstitial Lung Disease.Immunophenotyping of bronchoalveolar lavage lymphocytes.Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection.Oxidants/antioxidants in idiopathic pulmonary fibrosis.Expression of class II major histocompatibility complex antigens on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis.Bronchoalveolar lavage in the cat: cytological findings.Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP).Retrovirally introduced prostaglandin D2 synthase suppresses lung injury induced by bleomycin.Regulation of insulin-like growth factor I gene expression in the human macrophage-like cell line U937.Increased numbers of T lymphocytes with gamma delta-positive antigen receptors in a subgroup of individuals with pulmonary sarcoidosis.Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granulomaMacrophages cultured in vitro release leukotriene B4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan.Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators.Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies.Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.Two-hour methyl isocyanate inhalation and 90-day recovery study in B6C3F1 mice.Bone marrow-derived progenitor cells in pulmonary fibrosisType V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosisWhat causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust.Rising mortality from cryptogenic fibrosing alveolitis.Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disordersIncreased blood carboxyhaemoglobin concentrations in inflammatory pulmonary diseases.Analysis of bronchoalveolar lavage fluid in patients with chronic hepatitis C before and after treatment with interferon alpha.Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis.Acute tropical pulmonary eosinophilia. Characterization of the lower respiratory tract inflammation and its response to therapy.Alveolar macrophages release an insulin-like growth factor I-type moleculeSpontaneous expression of the c-sis gene and release of a platelet-derived growth factorlike molecule by human alveolar macrophages.Intraluminal fibrosis and elastic fiber degradation lead to lung remodeling in pulmonary Langerhans cell granulomatosis (histiocytosis X).Intraluminal fibrosis in interstitial lung disordersIdiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatmentHow T cells recognise antigen: implications for lung diseasesImmune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis.Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivityDoes serum angiotensin converting enzyme reflect intensity of alveolitis in sarcoidosis?
P2860
Q24813764-0C17239F-505A-4AEF-929D-4A2EF1523D10Q26341866-6D674529-76AF-44FC-9982-EE078643B9CFQ28388425-6672AE0A-5122-4264-8C95-EB4EC483CD2EQ33557157-C52350E5-4BBC-47F5-AB2B-AE5E6B2CE492Q33593575-1EADC923-D121-4405-8EE4-479F0AEE4AB1Q33604601-12787C11-3B49-4B25-9666-A7E7497B5B07Q33619174-D65B2013-3129-43A4-ACCA-C7D5CE5BA9EFQ33654538-B5026C9C-C901-433E-A731-E570760D4355Q33775924-29429BE4-B396-495B-B0FD-DFD74F9B85D0Q33821300-E69A89D4-8B94-4990-ACC0-5727BB3416DFQ33838014-49AD3910-8436-40E7-8818-FFC9E5ADBCDFQ34081352-95211BDA-297F-436E-8469-395A9B338B95Q34160036-CE98287C-93BA-43BB-81DD-79E6BFE03B1FQ34191947-B0904757-EE4D-4BDA-A179-C72F09583EB4Q34242647-C8AF71C0-041C-4DAB-B8F0-7F50CC4D50F5Q34249747-E9F7E329-6F5D-43DD-B617-FBC994ADE4A5Q34260434-A851A9AE-4D72-482E-BD06-71D933C5A378Q34263318-9459DC37-9C9B-45D4-A8B3-8932877A9889Q34525796-514A67AC-BB4C-4D35-AAED-31D31F312247Q34529157-B9FAB4EB-F8DC-4C1A-B9EA-62C3C41A222BQ34627050-4573F0CA-9AD1-4E95-BFA3-999515B7AA58Q34661085-F5514FFB-7672-4F2F-95DD-194003D68307Q35022598-74A26E65-304D-447C-A828-3BE2E3FCA877Q35034689-ACD3F7F1-08A9-485C-A888-1F06D7BBA6B6Q35170988-2BE332D0-A8A3-4957-A13D-2DD8811EB129Q35171005-BCC3CA74-B478-4B0A-BDAC-7551F58B06C4Q35532149-872D7883-C534-45F9-83CA-FF0501C489BDQ35535384-FD9FF144-F7D0-4596-8946-18D937793EABQ35563145-32FC1C7B-A357-4EB3-9205-5921A29A9A17Q35570378-28ED76A6-DEBC-4D4F-9D7E-016E61D29585Q35576006-82FC9C2C-7DC0-491C-9FBD-7E72A210FA62Q35593276-5618AA57-EFF7-4180-85BD-31507A378E07Q35807682-119AB22B-DB84-4CF8-B6A8-9A35B7DA3AFEQ35811801-F89973BC-FEC5-490A-AB96-C9757F04A519Q35835974-BE77474C-256A-4379-B47A-49525372C1A9Q35840808-2E4664DB-0384-4995-AFBF-675EC6C14F30Q35868117-B5DD7FAF-693B-41E8-B7A1-71E9D73A5BCFQ36012118-DD9A037F-E48E-445E-81A4-2E564E1FD175Q36146109-20B55E31-618A-4625-9B23-B772557B5E33Q36147162-E09B3AF2-9AD1-4D01-95FD-D8424C2575C4
P2860
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts).
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Interstitial lung diseases of ...... ry tract (first of two parts).
@en
type
label
Interstitial lung diseases of ...... ry tract (first of two parts).
@en
prefLabel
Interstitial lung diseases of ...... ry tract (first of two parts).
@en
P2093
P1476
Interstitial lung diseases of ...... ry tract (first of two parts).
@en
P2093
P304
P356
10.1056/NEJM198401193100304
P407
P577
1984-01-01T00:00:00Z